EcoR1 Capital — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Menlo Park, US
Board seatOleg Nodelman· per SEC Form D · $290M raise · filed Sep 2023
Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies.
Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US
Fabian Gerlinghaus(Co-Founder and Chief Executive Officer)inOmar Kurdi(Co-Founder and President)inVictor Tong(Director)in
BoardJustin Butler(Director)
BiotechSan Diego, US
Yi Liu(Executive Officer, Director)Lynn Yang(Director)
BoardCarl Gordon(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.